U.S. stock futures are trading mixed Wednesday as Wall Street awaits an announcement on tax cuts from the Trump administration.
You think the exchange is overvalued? I don't, and here's why.
Estimates for erenumab annual sales run as high as $2.3 billion.
Corporate America shelled out big bucks for President Trump's inauguration.